Ironwood Pharmaceuticals | 流动负债



金融业
股票价格
USD
资产
USD 396.06M
现金及等价物
USD 140.41M
销售成本
USD 29.83M
流动资产
USD 273.84M
流动负债
USD 242.5M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD -0.01
股本和储备
USD -264.16M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 535.3M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
USD 204.24
税前利润
USD 68.02M
销售收入
USD 47.71M
销售和管理费用
USD 33.33M
贸易债权人
USD 1.61M
应收帐款人
USD 81.89M


流动负债 更改 日
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Almirall EUR 350.64M 52.12M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amarin USD 182.23M 3.71M 2025-09
Ardelyx USD 83.39M 1.67M 2025-09
Astellas Pharma JPY 1.32T 873M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Coherus Biosciences USD 372.3M 108.67M 2025-09
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Esperion Therapeutics USD 359.03M 60.24M 2025-09
Exact Sciences USD 641.15M 56.89M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Lexicon Pharmaceuticals USD 34.84M 75.86M 2025-06
MacroGenics USD 44.47M 5.47M 2025-09
Moderna USD 1.99B 306M 2025-12
Myriad Genetics USD 148M 51.9M 2025-09
Pacira USD 120.59M 13.51M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12


Ironwood Pharmaceuticals 流动负债 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.